Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis
Nature.com - 05 Sep 2024Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis ...
sante.fr vaccination 75 ans
Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis ...
Association between Pandemic of COVID-19 and Influenza Vaccine Take-Up in 2020–2021 in Maine et Loire (France)
Wiley Online Library - 25 Jul 2024Association between Pandemic of COVID-19 and Influenza Vaccine Take-Up in 2020–2021 in Maine et Loire (France) ...
Understanding the gap between guidelines and influenza vaccination coverage in people with diabetes: a scoping review
Frontiers - 19 Apr 2024Understanding the gap between guidelines and influenza vaccination coverage in people with diabetes: a scoping review ...
When Lack of Trust in the Government and in Scientists Reinforces Social Inequalities in Vaccination Against COVID-19
Frontiers - 22 Feb 2024When Lack of Trust in the Government and in Scientists Reinforces Social Inequalities in Vaccination Against COVID-19 ...
French health authority recommends anti-bronchitis vaccine for over 75s
The Connexion - 04 Jul 2024French health authority recommends anti-bronchitis vaccine for over 75s ...
COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): An ecological study
ScienceDirect.com - 31 Jan 2022COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): An ecological study ...
Who can be vaccinated against mpox in France
The Local France - 16 Aug 2024Who can be vaccinated against mpox in France ...
Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster
nejm.org - 29 Mar 2023Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster ...
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna
The Lancet - 14 Nov 2022Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna ...
Covid-19: Primary vaccination for general population no longer recommended by the French health authority
Le Monde - 25 Feb 2023Covid-19: Primary vaccination for general population no longer recommended by the French health authority ...
From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics
BMC Medical Ethics - 28 Aug 2022From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics ...
Public health milestones through the years
World Health Organization - 03 Apr 2023Public health milestones through the years ...
France resumes use of AstraZeneca’s vaccine for those over 55, and the prime minister gets the shot. (Published 2021)
The New York Times - 19 Mar 2021France resumes use of AstraZeneca’s vaccine for those over 55, and the prime minister gets the shot. (Published 2021) ...
Psychometric validation of a 7C-model of antecedents of vaccine acceptance among healthcare workers, parents and adolescents in France | Scientific Reports
Nature.com - 14 Nov 2023Psychometric validation of a 7C-model of antecedents of vaccine acceptance among healthcare workers, parents and adolescents in France | Scientific Reports ...
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
The Lancet - 31 Jan 2022Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study ...
ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling
ScienceDirect.com - 22 Dec 2020ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling ...
Influenza vaccination coverage of professionals working in nursing homes in France and related determinants, 2018–2019 season: a cross-sectional survey
BMC Public Health - 25 May 2022Influenza vaccination coverage of professionals working in nursing homes in France and related determinants, 2018–2019 season: a cross-sectional survey ...
Manufacturing Consent for Vaccine Mandates: A Comparative Case Study of Communication Campaigns in France and Australia
Frontiers - 26 Jun 2024Manufacturing Consent for Vaccine Mandates: A Comparative Case Study of Communication Campaigns in France and Australia ...
Estimating COVID-19 vaccine uptake and its drivers among migrants, homeless and precariously housed people in France
Nature.com - 20 Feb 2023Estimating COVID-19 vaccine uptake and its drivers among migrants, homeless and precariously housed people in France ...